Alnylam Pharmaceuticals (ALNY) Cash from Investing Activities (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.28% |
| Dec 31, 2025 | -107.42% |
| Sep 30, 2025 | 454.44% |
| Jun 30, 2025 | -224.27% |
| Mar 31, 2025 | 315.02% |
| Dec 31, 2024 | -74.91% |
| Sep 30, 2024 | -189.13% |
| Jun 30, 2024 | 150.19% |
| Mar 31, 2024 | 71.90% |
| Dec 31, 2023 | -2,135.75% |
| Sep 30, 2023 | -23.54% |
| Jun 30, 2023 | 88.57% |
| Mar 31, 2023 | 45.52% |
| Dec 31, 2022 | -144.57% |
| Sep 30, 2022 | 119.82% |
| Jun 30, 2022 | 196.86% |
| Mar 31, 2022 | 64.34% |
| Dec 31, 2021 | -368.34% |
| Sep 30, 2021 | -156.21% |
| Jun 30, 2021 | 120.07% |
| Mar 31, 2021 | 172.89% |
| Dec 31, 2020 | -870.34% |
| Sep 30, 2020 | 97.71% |
| Jun 30, 2020 | -488.11% |
| Mar 31, 2020 | 151.48% |
| Dec 31, 2019 | -2,091.62% |
| Sep 30, 2019 | 96.52% |
| Jun 30, 2019 | -381.93% |
| Mar 31, 2019 | -58.77% |
| Dec 31, 2018 | 158.87% |
| Sep 30, 2018 | 53.58% |
| Jun 30, 2018 | 146.45% |
| Mar 31, 2018 | 16.05% |
| Dec 31, 2017 | -17.07% |
| Sep 30, 2017 | -102.71% |
| Jun 30, 2017 | -190.14% |
| Mar 31, 2017 | -25.22% |
| Dec 31, 2016 | 419.67% |
| Sep 30, 2016 | 29.16% |
| Jun 30, 2016 | -137.59% |
| Mar 31, 2016 | 50.68% |
| Dec 31, 2015 | 60.82% |
| Sep 30, 2015 | 145.51% |
| Jun 30, 2015 | 68.67% |
| Mar 31, 2015 | -1,692.39% |
| Dec 31, 2014 | -43.45% |
| Sep 30, 2014 | 116.60% |
| Jun 30, 2014 | 39.87% |
| Mar 31, 2014 | -777.60% |
| Dec 31, 2013 | 2,338.34% |
| Sep 30, 2013 | 95.29% |
| Jun 30, 2013 | 59.33% |
| Mar 31, 2013 | -400.69% |
| Dec 31, 2012 | 143.73% |
| Sep 30, 2012 | 134.88% |
| Jun 30, 2012 | 111.59% |
| Mar 31, 2012 | -415.59% |
| Dec 31, 2011 | -42.67% |
| Sep 30, 2011 | 1,274.71% |
| Jun 30, 2011 | -88.17% |
| Mar 31, 2011 | -53.16% |
| Dec 31, 2010 | 915.78% |
| Sep 30, 2010 | 117.37% |
| Jun 30, 2010 | -261.34% |
| Mar 31, 2010 | -113.42% |
| Dec 31, 2009 | 285.68% |